Sight Sciences Q3 2023 EPS $(0.27) Beats $(0.32) Estimate, Sales $20.01M Miss $21.59M Estimate
Portfolio Pulse from totan@benzinga.com
Sight Sciences (NASDAQ:SGHT) reported Q3 2023 earnings per share (EPS) of $(0.27), beating the analyst consensus estimate of $(0.32) by 15.62%. This is a 41.3% increase over losses from the same period last year. However, the company's quarterly sales of $20.01 million missed the analyst consensus estimate of $21.59 million by 7.32%, despite a 7.13% increase over sales from the same period last year.
November 07, 2023 | 9:18 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Sight Sciences reported better than expected Q3 2023 EPS but missed sales estimates. The EPS beat may boost investor confidence, while the sales miss could raise concerns about growth.
Sight Sciences reported a better than expected EPS for Q3 2023, which could boost investor confidence and potentially lead to a short-term increase in the stock price. However, the company missed sales estimates, which could raise concerns about its growth prospects and potentially put downward pressure on the stock. The net impact on the stock is uncertain, hence the neutral score.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100